Skip to Main Content

Advertisement

Skip Nav Destination
Issue Cover
Current Issue
Volume 8,
Issue 7,
April 9 2024

Advertisement




Featured Content

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia

Deciphering the regulatory landscape of murine splenic response to anemic stress at single-cell resolution

Aberrant GPA expression and regulatory function of red blood cells in sickle cell disease

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement